Mechanistically, Gliclazide inhibited the proliferation of lung adenocarcinoma cells possibly by targeting CCNB1, CCNB1, CDK1 and AURKA to induce cell cycle arrest and apoptosis. This evidence concerns the gene AURKA and lung adenocarcinoma.